These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25590321)

  • 1. Does atopy influence the effectiveness of treatment of adenoid hypertrophy with mometasone furoate?
    Rezende RM; Amato FS; Barbosa AP; Menezes UP; Rezende P; Ferriani VP; Anselmo-Lima WT; Valera FC
    Am J Rhinol Allergy; 2015; 29(1):54-6. PubMed ID: 25590321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Objective reduction in adenoid tissue after mometasone furoate treatment.
    Rezende RM; Silveira F; Barbosa AP; Menezes UP; Ferriani VP; Rezende PH; Anselmo-Lima WT; Valera FC
    Int J Pediatr Otorhinolaryngol; 2012 Jun; 76(6):829-31. PubMed ID: 22425063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical observation of mometasone furoate nasal spray combined with montelukast sodium in the treatment of adenoid hypertrophy in children].
    Liu W; Chen RJ
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):366-368. PubMed ID: 29871263
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of topical nasal steroids in the treatment of children with otitis media with effusion and/or adenoid hypertrophy.
    Cengel S; Akyol MU
    Int J Pediatr Otorhinolaryngol; 2006 Apr; 70(4):639-45. PubMed ID: 16169093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of mometasone furoate aqueous nasal spray in the treatment of adenoidal hypertrophy in the pediatric age group: preliminary results of a prospective, randomized study.
    Berlucchi M; Salsi D; Valetti L; Parrinello G; Nicolai P
    Pediatrics; 2007 Jun; 119(6):e1392-7. PubMed ID: 17533178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and meta-analysis of randomized controlled trials on the role of mometasone in adenoid hypertrophy in children.
    Chohan A; Lal A; Chohan K; Chakravarti A; Gomber S
    Int J Pediatr Otorhinolaryngol; 2015 Oct; 79(10):1599-608. PubMed ID: 26235732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effects of montelukast, mometasone furoate, and combined therapyon adenoid size: a randomized, prospective, clinical trial with objective data.
    Tuhanıoğlu B; Erkan SO
    Turk J Med Sci; 2017 Dec; 47(6):1736-1743. PubMed ID: 29306232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of children undergoing topical intranasal steroid therapy for adenoidal hypertrophy.
    Berlucchi M; Valetti L; Parrinello G; Nicolai P
    Int J Pediatr Otorhinolaryngol; 2008 Aug; 72(8):1171-5. PubMed ID: 18499270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind randomized placebo-controlled trial of topical intranasal mometasone furoate nasal spray in children of adenoidal hypertrophy with otitis media with effusion.
    Bhargava R; Chakravarti A
    Am J Otolaryngol; 2014; 35(6):766-70. PubMed ID: 25151658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of mometasone furoate aqueous nasal spray for management of adenoidal hypertrophy in children.
    Bhargava R; Chakravarti A
    J Laryngol Otol; 2014 Dec; 128(12):1060-6. PubMed ID: 25404102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of mometasone furoate nasal spray in the treatment of adenoidal hypertrophy in the adolescents: a prospective, randomized, cross-over study.
    Yilmaz HB; Celebi S; Sahin-Yilmaz A; Oysu C
    Eur Arch Otorhinolaryngol; 2013 Sep; 270(10):2657-61. PubMed ID: 23381494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Montelukast combined with intranasal mometasone furoate versus intranasal mometasone furoate; a comparative study in treatment of adenoid hypertrophy.
    Ras AE; Hamed MH; Abdelalim AA
    Am J Otolaryngol; 2020; 41(6):102723. PubMed ID: 32950830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the characteristics of children with obstructive adenoid responding to mometasone fuorate monohydrate: preliminary results.
    Bitar MA; Mahfoud L; Nassar J; Dana R
    Eur Arch Otorhinolaryngol; 2013 Mar; 270(3):931-7. PubMed ID: 23010795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of topical mometasone furoate on adenoidal lymphoid tissue: a light microscopic study.
    Ahmed MR; Abou-Halawa AS; Ibrahim IH; Zittoon RF; Makary EFY
    J Laryngol Otol; 2019 Feb; 133(2):106-109. PubMed ID: 30616699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mometasone furoate intranasal spray is effective in reducing symptoms and adenoid size in children and adolescents with adenoid hypertrophy.
    Ghafar MHA; Mohamed H; Mohammad NMY; Mohammad ZW; Madiadipoera T; Wang Y; Abdullah B
    Acta Otorrinolaringol Esp (Engl Ed); 2020; 71(3):147-153. PubMed ID: 31400807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
    Mandl M; Nolop K; Lutsky BN
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The influence of medical treatment of the perennial allergic rhinitis on the adenoid size in children].
    Modrzyński M; Zawisza E; Mazurek H
    Otolaryngol Pol; 2006; 60(4):543-50. PubMed ID: 17152807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of efficacy of mometasone furoate versus clarithromycin in the treatment of chronic rhinosinusitis without nasal polyps in Chinese adults.
    Zeng M; Long XB; Cui YH; Liu Z
    Am J Rhinol Allergy; 2011; 25(6):e203-7. PubMed ID: 22185725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intranasal mometasone furoate on itchy ear and palate in patients with seasonal allergic rhinitis.
    Bernstein DI; Teper A; Gopalan G; Gates D
    Ann Allergy Asthma Immunol; 2012 May; 108(5):359-62. PubMed ID: 22541408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid.
    Ahlström-Emanuelsson C; Persson CG; Svensson C; Andersson M; Hosszu Z; Akerlund A; Greiff L
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):159-65. PubMed ID: 12197572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.